exelixis.net
Pipeline | Exelixis
http://www.exelixis.net/pipeline
The Exelixis pipeline includes our lead compounds, cabozantinib and cobimetinib, as well as other programs that are the subject of partnerships and collaborations with other biopharmaceutical companies. An additional wholly-owned compound, XL888, is the subject of ongoing clinical research through our Investigator-Sponsored Trial. Program. Safety and efficacy for these compounds in the unapproved uses or indications described below have not yet been established. XL888 is a highly potent, orally bioavaila...
exelixis.net
Stock Information | Exelixis
http://www.exelixis.net/investors-media/stock-information
National Cancer Institute Sponsored Trials. FAQs about Clinical Trials. Exelixis, Inc. 2016 Website design. Hane Chow, Inc.
exelixis.net
Earnings Ratings | Exelixis
http://www.exelixis.net/investors-media/earnings-ratings
National Cancer Institute Sponsored Trials. FAQs about Clinical Trials. Exelixis, Inc. 2016 Website design. Hane Chow, Inc.
exelixis.com
Frequently Asked Questions about Clinical Trials | Exelixis
http://www.exelixis.com/clinical-trials/faq
Frequently Asked Questions about Clinical Trials. I am a patient who is interested in getting on a trial with cabozantinib. How do I find out more information? For additional information on participating in a clinical trial of cabozantinib, please visit www.ClinicalTrials.gov. Or contact Exelixis Medical Information at 1-888-EXELIXIS or at druginfo@exelixis.com. I am a health care practitioner who wants to put one of my patients on a cabozantinib trial. What steps do I need to take? Hane Chow, Inc.
exelixis.net
Annual Reports | Exelixis
http://www.exelixis.net/investors-media/annual-reports
National Cancer Institute Sponsored Trials. FAQs about Clinical Trials. Exelixis, Inc. 2016 Website design. Hane Chow, Inc.
exelixis.net
Clinical Trials | Exelixis
http://www.exelixis.net/clinical-trials
Exelixis is conducting a broad global clinical development program for cabozantinib in a wide variety of cancer settings. The program includes multiple Exelixis-sponsored global, randomized phase 3 pivotal trials, as well as earlier stage studies conducted through our Investigator-Sponsored Trial program and our collaboration with the National Cancer Institute’s Cancer Therapy Evaluation Program. National Cancer Institute Sponsored Trials. FAQs about Clinical Trials. FAQs about Clinical Trials.
exelixis.com
Investigator Sponsored Trials | Exelixis
http://www.exelixis.com/clinical-trials/investigator_sponsored_trials
Cabozantinib is also being evaluated in a variety of investigator sponsored trials (ISTs). You can access a detailed list of cabozantinib clinical studies, including ISTs, at www.ClinicalTrials.gov. For further information regarding all clinical trials, please contact Exelixis Medical Information at 1-888-EXELIXIS (1-888-393-5494) or at druginfo@exelixis.com. National Cancer Institute Sponsored Trials. FAQs about Clinical Trials. National Cancer Institute Sponsored Trials. FAQs about Clinical Trials.
exelixis.net
National Cancer Institute Sponsored Trials | Exelixis
http://www.exelixis.net/clinical-trials/national_cancer_institute_sponsored_trials
National Cancer Institute Sponsored Trials. You can access a detailed list of cabozantinib clinical studies, including NCI-CTEP trials, at www.ClinicalTrials.gov. For further information regarding all clinical trials, please contact Exelixis Medical Information at 1-888-EXELIXIS (1-888-393-5494) or at druginfo@exelixis.com. National Cancer Institute Sponsored Trials. FAQs about Clinical Trials. National Cancer Institute Sponsored Trials. FAQs about Clinical Trials. Exelixis, Inc. 2016 Website design.
exelixis.net
Investors & Media | Exelixis
http://www.exelixis.net/investors-media
National Cancer Institute Sponsored Trials. FAQs about Clinical Trials. Exelixis, Inc. 2016 Website design. Hane Chow, Inc.
exelixis.net
Management and Board | Exelixis
http://www.exelixis.net/investors-media/management-board
National Cancer Institute Sponsored Trials. FAQs about Clinical Trials. Exelixis, Inc. 2016 Website design. Hane Chow, Inc.